FOLD
Amicus Therapeutics Inc
NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY
$14.49
+0.00% today
Updated 2026-04-27
Market cap
$4.55B
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$6 – $15
Volume
3.5M
Amicus Therapeutics Inc (FOLD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $59.65M | $167.10M | $128.77M | $85.37M | $112.55M | $69.80M | $110.09M | $127.56M | $209.97M | $908.38M | $1.04B | $627.02M | $789.95M | $850.21M | $886.52M | $905.14M | $724.17M | $777.88M | $785.03M | $949.87M |
| Cash & equivalents | $12.13M | $44.19M | $28.07M | $19.34M | $29.57M | $25.67M | $33.97M | $43.64M | $24.07M | $69.48M | $187.03M | $49.06M | $79.75M | $142.84M | $163.24M | $245.20M | $148.81M | $246.99M | $213.75M | $214.01M |
| Current assets | $55.02M | $163.04M | $123.59M | $80.49M | $109.68M | $66.65M | $104.62M | $88.28M | $154.58M | $216.60M | $340.06M | $391.96M | $551.10M | $520.07M | $579.47M | $596.83M | $423.82M | $483.06M | $504.74M | $676.17M |
| Total liabilities | $137.16M | $63.80M | $57.73M | $13.54M | $47.62M | $40.20M | $40.87M | $81.81M | $87.79M | $560.55M | $676.69M | $274.17M | $447.04M | $373.78M | $600.14M | $597.77M | $601.12M | $617.71M | $590.99M | $675.63M |
| Current liabilities | $10.21M | $15.79M | $13.38M | $11.19M | $16.22M | $19.26M | $9.24M | $10.46M | $20.18M | $73.62M | $110.96M | $70.04M | $86.13M | $128.81M | $129.68M | $145.97M | $139.02M | $167.69M | $148.70M | $237.83M |
| Long-term debt | $2.26M | $1.19M | $317000.00 | $2.34M | $1.04M | $0.00 | $299000.00 | $14.17M | $10.51M | $41.60M | $154.46M | $164.17M | $321.74M | $149.50M | $389.25M | $389.36M | $391.99M | $387.86M | $390.11M | — |
| Shareholder equity | $-77.52M | $103.30M | $71.04M | $71.83M | $64.93M | $29.59M | $69.22M | $45.75M | $122.18M | $347.83M | $360.15M | $352.85M | $342.91M | $476.43M | $286.38M | $307.37M | $123.05M | $160.17M | $194.04M | $274.24M |
| Retained earnings | $-83.67M | $-124.83M | $-164.19M | $-170.76M | $-225.69M | $-270.10M | $-318.89M | $-378.52M | $-447.45M | $-579.57M | $-779.61M | $-1.06B | $-1.41B | $-1.77B | $-2.05B | $-2.30B | $-2.53B | $-2.68B | $-2.74B | $-2.77B |
| Accounts receivable | — | — | — | — | — | $5.04M | $3.23M | $1.08M | $1.30M | — | $1.30M | $9.46M | $21.96M | $33.28M | $46.92M | $52.67M | $66.20M | $87.63M | $101.10M | $115.31M |
| Inventory | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.42M | $4.62M | $8.39M | $14.04M | $19.56M | $26.82M | $23.82M | $59.70M | $118.78M | $228.82M |
| Goodwill | — | — | — | — | — | $0.00 | $0.00 | $11.61M | $11.61M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M |